Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinoma
Thapa, D. R.; Deodhar, R.; Skepner, A.; Konda, P.; Zhou, M.; Bluck, J.; Pichlo, C.; Cui, Y.; Stocker, P.; Khanna, P.; Li, J.; Tsai, J.; Leed, A.; Gould, S.; Alimova, M.; Friedrich, D.; Cheah, J. H.; Rupaimoole, R.; Guicherit, O.; Viswanathan, S. R.
Show abstract
Translocation renal cell carcinoma (tRCC) is an aggressive kidney cancer driven by gene fusions of the TFE3 transcription factor. TFE3 is essential in tRCC but dispensable in normal cells, presenting an attractive but pharmacologically challenging therapeutic target. We show that the basic helix-loop-helix (bHLH) domain of TFE3 is crucial for chromatin binding and transcriptional function. Via a phenotypic screen of 25,000 compounds, we identified molecules that either displace or retain chromatin-bound TFE3. BRD6866, a compound trapping TFE3 on chromatin, emerged as a pan-CDK inhibitor. Mechanistically, its inhibition of CDK9 - a key regulator of transcriptional elongation - was linked to impaired TFE3 fusion activity. These effects were recapitulated by the CDK9-selective inhibitor enitociclib, which downregulated TFE3 targets and suppressed tRCC cell growth. Our findings nominate CDK9 inhibition as a therapeutic strategy in tRCC and demonstrate the utility of mechanism-informed phenotypic screening for challenging targets.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinical PARP inhibitors allosterically induce PARP2 retention on DNA 95%
- CRISPR/Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells 95%
- Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas 95%
Similar papers in this journal
Similar papers in this journal
- Simultaneous inhibition of DNA-PK and Pol{Theta} improves integration efficiency and precision of genome editing 95%
- MaTAR25 LncRNA Regulates the Tensin1 Gene to Impact Breast Cancer Progression 95%
- CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effect 94%
Similar papers in this journal
Similar papers in this journal
- Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer 95%
- SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species 95%
- Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.